title: Temporal expression of urokinase type plasminogen activator, tissue type plasminogen activator, plasminogen activator inhibitor type 1 in rhesus monkey corpus luteum during the luteal maintenance and regression.
abstract: Proteolytic activity generated by the plasminogen activator (PA) system has been associated with many biological processes. Using a pregnant mare serum gonadotropin (PMSG)/human chorionic gonadotropin (hCG)-induced rhesus monkey corpus luteum (CL) model, we have studied how urokinase-type plasminogen activator (uPA), tissue-type plasminogen activator (tPA), and plasminogen activator inhibitor type 1 (PAI-1), are temporally expressed in CL of rhesus monkey at the luteotropic and luteolytic periods. Slot blot analysis and in situ hybridization were performed to analyze the expression and distribution of uPA and PAI-1 messenger RNA (mRNA). Fibrin overlay was used to detect uPA and tPA activities. We found that uPA is the dominating PA in luteotropic CL in the monkey. Abundant expression of PAI-1 mRNA was detected. The highest expression of uPA and PAI-1 mRNA was observed at the luteotropic period, while their expression decreased approximately 50% at early luteal regression defined by considerably decreased serum progesterone levels, and remained at very low levels at the late stage of luteal regression. We also observed an increased tPA activity at the time of luteal regression. Moreover, the exogenous tPA could inhibit the progesterone production in cultured luteal cells from 13-day-old monkey CL. We also used LH receptor mRNA expression as a mark for the luteal phases. A highly expressed, evenly distributed LH receptor mRNA was detected in CL during the luteotropic phase, while its expression decreased at day 13 coinciding with the reduction of progesterone production. We conclude that proteolysis mediated by uPA and regulated by PAI-1 may play a role in the luteal maintenance, while tPA may participate in the luteal regression in the rhesus monkey.
authors.affiliation: Department of Medical Biochemistry and Biophysics, University of Umeå, Sweden.
authors.forename: K
authors.initials: K
authors.lastname: Liu
authors.forename: Y X
authors.initials: YX
authors.lastname: Liu
authors.forename: Z Y
authors.initials: ZY
authors.lastname: Hu
authors.forename: R Y
authors.initials: RY
authors.lastname: Zou
authors.forename: Y J
authors.initials: YJ
authors.lastname: Chen
authors.forename: X M
authors.initials: XM
authors.lastname: Mu
authors.forename: T
authors.initials: T
authors.lastname: Ny
mesh_terms: D000818:Animals; D006063:Chorionic Gonadotropin; D003338:Corpus Luteum / Q000378:metabolism* / Q000502:physiology; D003340:Corpus Luteum Maintenance / Q000235:genetics*; D005260:Female; D005786:Gene Expression Regulation / Q000502:physiology; D006064:Gonadotropins, Equine; D008184:Luteal Cells / Q000378:metabolism; D003341:Luteolysis / Q000235:genetics*; D008253:Macaca mulatta; D017395:Plasminogen Activator Inhibitor 1 / Q000235:genetics*; D011247:Pregnancy; D011374:Progesterone / Q000096:biosynthesis / Q000097:blood; D012333:RNA, Messenger / Q000032:analysis; D011974:Receptors, LH / Q000235:genetics; D010959:Tissue Plasminogen Activator / Q000235:genetics* / Q000378:metabolism / Q000494:pharmacology; D014568:Urokinase-Type Plasminogen Activator / Q000235:genetics* / Q000378:metabolism
chemical_list: D006063:Chorionic Gonadotropin; D006064:Gonadotropins, Equine; D017395:Plasminogen Activator Inhibitor 1; D012333:RNA, Messenger; D011974:Receptors, LH; D011374:Progesterone; D010959:Tissue Plasminogen Activator; D014568:Urokinase-Type Plasminogen Activator